Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structureeactivity relationship and biological activity as potential antitumor and anticonvulsant agents | noha Samir

Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structureeactivity relationship and biological activity as potential antitumor and anticonvulsant agents

Citation:: Latif, N. A. S., P. H. O. E. B. E. F. LAMIE, A. M. El-Kalaawy, L. A. Rashed, and J. N. Philoppes, "Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structureeactivity relationship and biological activity as potential antitumor and anticonvulsant agents", European Journal of Medicinal Chemistry, vol. 214, issue 113222, 2021.